Insulet | PODD - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 9.31B 104M 2026-03
Align Technology USD 862.03M 39.18M 2026-03
AtriCure USD 140.72M 2.71M 2026-03
Avanos Medical USD 782.1M 625.97M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Cardinal Health USD -2.83B 52M 2026-03
Cooper Companies USD 1.11B 301.2M 2026-03
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Globus Medical USD 595.85M 49.26M 2026-03
ICU Medical USD 514.62M 4.48M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
J&J USD 17.44B 1.53B 2026-03
Masimo USD 326.2M 2.4M 2026-03
Medtronic USD 7.72B 436M 2026-03
Merit Medical Systems USD 337.72M 2.02M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Solventum Corp USD 4.97B 3.08B 2026-03
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
West Pharmaceutical Services USD 2.99B 2.35B 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03